In the only planned and final OS analysis of the HARMONi-A study, ivonescimab plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement when compared with ...
In this Hogan Lovells update, we first provide a brief overview of the purpose and history of the PCHF Draft Guidance, address the key changes to the draft Introduction, and then discuss some of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results